SEC Filing Summary: Form 8-K
Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) for the reporting period ending May 19, 2005. The registrant is incorporated in California with principal executive offices in Menlo Park, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Board Departure: Kirby L. Cramer retired as a member of the Board of Directors effective May 19, 2005.
- Bylaw Amendment: The Board approved an amendment and restatement of the Company's Bylaws to decrease the number of directors from nine (9) to eight (8), effective May 19, 2005.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the departure of a director and the reduction in board size.
Investor Verification Checklist
- Verify the identity of the registrant as Landec Corporation, distinct from Lifecore Biomedical, Inc.
- Confirm the effective date of Kirby L. Cramer's retirement (May 19, 2005).
- Review the attached Exhibit 3.1 (Amended and Restated Bylaws) for details on the reduction of the board size to eight members.